Liver Cirrhosis Unknown Status Phase 4 Trials for Rifaximin (DB01220)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02074280Rifaximin Predicts the Complications of Decompensated CirrhosisPrevention
NCT00748904Rifaximin Versus Lactulose in Renal FailureTreatment